24/7 Customer Support

+1 718 473 0872

Pharmaceutical Markets in the US

Solid Q on top and bottom Lines

  • January 2012
  • 23 pages

Download This Report Now!

We value your privacy and will never rent or sell your email address.
Privacy Policy by TRUSTe

  • Geographic Coverage

    United States  

    World  

  • Type of data

    Demand  

  • Price Objective Change 1
  • iQmethod SM - Bus Performance* 2
  • (US$ Millions) 2
  • iQmethod SM - Quality of Earnings* 2
  • Income Statement Data (Dec) (US$ Millions) 2
  • Free Cash Flow Data (Dec) (US$ Millions) 2
  • Balance Sheet Data (Dec) (US$ Millions) 2
  • Company Description 2
  • Stock Data 2
  • Quarterly Earnings Estimates 2
  • Investment Thesis 2
  • Teva Pharmaceutical Industries Annual Earnings Model 4
  • Teva Pharmaceutical Industries Quarterly Revenue Model (continued) 7
  • Teva Pharmaceutical Industries Annual Revenue Model 9
  • Teva Pharmaceutical Industries Annual Revenue Model (continued) 10
  • Price objective basis & risk 19
  • Link to Definitions 19
  • Analyst Certification 19
  • BofA Merrill Lynch ticker Bloomberg symbol Analyst 19
  • iQmethod SM Measures Definitions 20
  • Business Performance 20
  • Quality of Earnings 20
  • Valuation Toolkit 20
  • Numerator 20
  • Denominator 20
  • Investment Rating Distribution: Global Group (as of 01 Jan 2012) Coverage
  • Universe 21
  • Count 21
  • Percent 21
  • Inv. Banking Relationships* 21
  • Count 21
  • Percent 21
  • FUNDAMENTAL EQUITY OPINION KEY: Opinions include a Volatility Risk Rating, an
  • Investment Rating and an Income Rating. VOLATILITY RISK 21
  • Count 21
  • Investment Rating Distribution: Health Care Group (as of 01 Jan 2012) Coverage
  • Universe 21
  • Merrill Lynch representative or Merrill Lynch Global Wealth Management financial
  • advisor if they have questions concerning this report. 22
  • Information relating to Non-US affiliates of BofA Merrill Lynch and Distribution
  • of Affiliate Research Reports 22
  • General Investment Related Disclosures 22
  • Other Important Disclosures 22
  • Copyright and General Information regarding Research Reports 23
  • Price Objective Change 1
  • Teva Pharmaceutical Industries Quarterly Earnings Model 3
  • Teva Pharmaceutical Industries Quarterly Revenue Model 5
  • Teva Pharmaceutical Industries Quarterly Revenue Model (continued) 6
  • Teva Pharmaceutical Industries Copaxone Model 13
  • Teva Pharmaceutical Industries Provigil & Nuvigil Sales Model 16
  • Teva Pharmaceutical Industries Actiq & Fentora Sales Model 17
  • Teva Pharmaceutical Industries US Amrix Sales Model 18
  • Important Disclosures 21

Refine your search results

10 Companies

Company Profiles

Shire PLC

United Kingdom

Ferring B.V.

Netherlands

Roche Holding AG

Switzerland

SYNTHES Inc.

Switzerland

Biogen Idec

United States

Pervel Industries Inc.

United States

Biosense Webster Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.